SEP has acquired a minority stake in Exco InTouch which will use the funds to drive its growth in the clinical technology sector, especially in the mobile patient communication market.
Exco InTouch has developed a suite of patient-focused services which are delivered using a combination of cell-phone and internet technology.
The company’s services used in clinical trials support patient recruitment and retention, helping the electronic capture of patient reported outcomes data (ePRO) during clinical trials and in Late Phase observational studies.
The company has provided Pfizer with the mobile clinical trial technology in its Remote study.